BEOffers Opt-In

As a member of the Breathe Easier Program, sign up now to get our online communications!
You’ll get access to helpful links to get more information about asthma and its treatments, customized communications, and money-saving offers.†

Please provide your name and address as it appears on the letter you received. This will help us confirm that you are a member of the Breathe Easier Program.

*Required fields

*E-mail:

*Confirm e-mail:
*First Name:
*Last Name:
*Address:

*City:
*State:	*ZIP:

We ask for your e-mail address so that we may send you up to 6
e-mails with online offers during a 12-month period.

We respect your privacy and will not share or sell your information to any third party for their own use. See our privacy statement.

You may choose to discontinue your participation at any time.

Which of the following medication(s) do you currently take to treat your asthma?


	Accolate^®
	ADVAIR DISKUS^® (fluticasone propionate and salmeterol inhalation powder)
	Aerobid^®/Aerobid^®-M
	Albuterol
	Azmacort^®
	FLOVENT^® HFA (fluticasone propionate) Inhalation Aerosol
	Foradil^®


	Proventil^®/Proventil^® HFA
	Pulmicort Turbuhaler^®
	QVAR^®
	Singulair^®
	Theophylline (eg, Slo-Bid, Theo-Dur^®, Theo-24^®)
	VENTOLIN^® HFA (albuterol sulfate HFA inhalation aerosol)

By providing your name, address, e-mail address, and other information, you are giving GlaxoSmithKline (GSK) and companies working with GSK permission to market or advertise to you regarding the medical condition(s) in which you've expressed an interest, as well as other general health related information from GSK. GlaxoSmithKline will not sell or transfer your name, address, or e-mail address to any other party for their own marketing use.

For additional information on how GSK handles your information, please read our privacy statement.

The brands listed, with the exceptions of ADVAIR DISKUS, FLOVENT, and VENTOLIN, are trademarks of their respective owners and are not trademarks of The GlaxoSmithKline Group of Companies. The makers of these brands are not affiliated with and do not endorse GlaxoSmithKline or its products.

*People ages 12 years and older taking ADVAIR 100/50 experienced improvements in lung function and reductions in both asthma symptoms and fast-acting inhaler use, compared with people taking either fluticasone propionate 100 mcg or salmeterol 50 mcg (inhalation powders) alone. Your results may vary.

†Subject to eligibility. Restrictions apply. Click here for eligibility rules.

‡While supplies last. Please allow 6-8 weeks for delivery. Limit 1 per person. This offer expires 12/31/2008.

Important Information about ADVAIR DISKUS
Prescription ADVAIR won't replace fast-acting inhalers for sudden symptoms and should not be taken more than twice a day. ADVAIR is for people who still have symptoms on another asthma controller, or who need two controllers. ADVAIR contains salmeterol. In patients with asthma, medicines like salmeterol may increase the chance of asthma-related death. So ADVAIR is not for people whose asthma is well controlled on another controller medicine.

Talk to your doctor about the risks and benefits of treating your asthma with ADVAIR. Do not use ADVAIR with long-acting beta₂-agonists for any reason. If you are taking ADVAIR, see your doctor if your asthma does not improve or gets worse. Tell your doctor if you have a heart condition or high blood pressure. Some people may experience increased blood pressure, heart rate, or changes in heart rhythm. ADVAIR is for patients 4 years and older. For patients 4 to 11 years old, ADVAIR 100/50 is for those who have asthma symptoms while on an inhaled corticosteroid.

Important Information about FLOVENT HFA:
Prescription FLOVENT HFA Inhalation Aerosol is for patients with asthma 4 years of age and older.

FLOVENT HFA is also for patients who are taking oral steroids, like prednisone, for asthma. Many of these patients may be able to reduce or eliminate their use of oral steroids over time. FLOVENT HFA does not replace fast-acting (rescue) inhalers for sudden symptoms. The use of FLOVENT HFA in children 4 to 11 years old is based in part on results of studies in patients 12 years and older and other FLOVENT products.

Important Information about VENTOLIN HFA:
Prescription VENTOLIN HFA is indicated for the prevention and relief of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease.

If you find that your symptoms become significantly worse when you use VENTOLIN, contact your doctor immediately because this reaction can be life threatening. When this worsening occurs, it is frequently with the first use of a new inhaler. Tell your doctor if you have a heart, blood, or seizure disorder, high blood pressure, diabetes, or an overactive thyroid. Some medicines can interfere with how well asthma medications work. Tell your doctor about all medicines you are taking, especially heart medicines and drugs that treat depression. In clinical trials, the most common side effects with VENTOLIN were throat irritation, viral respiratory infections, upper respiratory swelling, cough, and muscle pain. The side effect profile in children was generally similar to that of adults.

Complete Prescribing Information and Medication Guide for ADVAIR DISKUS^® (fluticasone propionate and salmeterol inhalation powder).
Complete Prescribing Information for FLOVENT^® HFA (fluticasone propionate) Inhalation Aerosol.
Complete Prescribing Information for VENTOLIN^® HFA (albuterol sulfate HFA inhalation aerosol).

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.